Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort
Abstract Background The purpose was to evaluate the prognostic impact of aryl hydrocarbon receptor (AHR) genotypes in relation to lifestyle and adjuvant treatments in breast cancer. Methods AHR genotyping was performed on genomic DNA from 1701 patients included 2002–2016 in Lund, Sweden, and followe...
Saved in:
| Main Authors: | Annelie Augustinsson, Christopher Godina, Linn Nilsson, Kelin Gonçalves de Oliveira, Karolin Isaksson, Helena Jernström |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | BJC Reports |
| Online Access: | https://doi.org/10.1038/s44276-025-00167-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome.
by: Christopher Godina, et al.
Published: (2024-01-01) -
Phenotype refinement strengthens the association of AHR and CYP1A1 genotype with caffeine consumption.
by: George McMahon, et al.
Published: (2014-01-01) -
The AhR pathway is dysregulated in alopecia areata
by: Arno Belpaire, et al.
Published: (2025-06-01) -
The Complex Interplay of Genetic and Lifestyle Risk Factors in Type 2 Diabetes: An Overview
by: Paul W. Franks
Published: (2012-01-01) -
AhR governs lipid metabolism: the role of gut microbiota
by: Wanru Zheng, et al.
Published: (2025-01-01)